missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ RCBTB1 Polyclonal Antibody

Description
Recommended positive controls: MCF-7. Predicted reactivity: Mouse (93%), Rat (93%), Zebrafish (81%), Rhesus Monkey (100%), Bovine (99%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
This gene encodes a protein with an N-terminal RCC1 domain and a C-terminal BTB (broad complex, tramtrack and bric-a-brac) domain. In rat, over-expression of this gene in vascular smooth muscle cells induced cellular hypertrophy. In rat, the C-terminus of RCBTB1 interacts with the angiotensin II receptor-1A. In humans, this gene maps to a region of chromosome 13q that is frequently deleted in B-cell chronic lymphocytic leukemia and other lymphoid malignancies.
Spécification
Spécification
| Antigène | RCBTB1 |
| Applications | Western Blot |
| Classification | Polyclonal |
| Concentration | 0.69 mg/mL |
| Conjugué | Unconjugated |
| Formule | 0.1M tris glycine with 20% glycerol and 0.01% thimerosal; pH 7 |
| Expression | RCBTB1 |
| Numéro d’ordre du gène | Q8NDN9 |
| Alias de gène | 5430409I18Rik; AW111883; Chronic lymphocytic leukemia deletion region gene 7 protein; CLL deletion region gene 7 protein; CLLD7; CLLL7; E4.5; GDP/GTP exchange factor (GEF)-like protein; GLP; RCBTB1; RCC1 and BTB domain containing protein 1; RCC1 and BTB domain-containing protein 1; regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 1; regulator of chromosome condensation and BTB domain-containing protein 1; RP11-185C18.1 |
| Symboles de gène(s) | RCBTB1 |
| Afficher plus |
Nom du produit
En cliquant sur Soumettre, vous reconnaissez que vous pouvez être contacté par Fisher Scientific au sujet des informations que vous avez fournies dans ce formulaire. Nous ne partagerons pas vos informations à d'autres fins. Toutes les informations de contact fournies seront également conservées conformément à notre politique de confidentialité. Politique de confidentialité.
Vous avez repéré une opportunité d'amélioration ?